Unknown

Dataset Information

0

Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.


ABSTRACT: MicroRNA-499 and other members of the myomiR family regulate myosin isoforms in pressure-overload hypertrophy. miR-499 expression varies in human disease, but results of mouse cardiac miR-499 overexpression are inconsistent, either protecting against ischemic damage or aggravating cardiomyopathy after pressure overload. Likewise, there is disagreement over direct and indirect cardiac mRNAs targeted in vivo by miR-499.To define the associations between regulated miR-499 level in clinical and experimental heart disease and modulation of its predicted mRNA targets and to determine the consequences of increased cardiac miR-499 on direct mRNA targeting, indirect mRNA modulation, and on myocardial protein content and posttranslational modification.miR-499 levels were increased in failing and hypertrophied human hearts and associated with decreased levels of predicted target mRNAs. Likewise, miR-499 is increased in Gq-mediated murine cardiomyopathy. Forced cardiomyocyte expression of miR-499 at levels comparable to human cardiomyopathy induced progressive murine heart failure and exacerbated cardiac remodeling after pressure overloading. Genome-wide RNA-induced silencing complex and RNA sequencing identified 67 direct, and numerous indirect, cardiac mRNA targets, including Akt and MAPKs. Myocardial proteomics identified alterations in protein phosphorylation linked to the miR-499 cardiomyopathy phenotype, including of heat shock protein 90 and protein serine/threonine phosphatase 1-?.miR-499 is increased in human and murine cardiac hypertrophy and cardiomyopathy, is sufficient to cause murine heart failure, and accelerates maladaptation to pressure overloading. The deleterious effects of miR-499 reflect the cumulative consequences of direct and indirect mRNA regulation, modulation of cardiac kinase and phosphatase pathways, and higher-order effects on posttranslational modification of myocardial proteins.

SUBMITTER: Matkovich SJ 

PROVIDER: S-EPMC3429338 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy.

Matkovich Scot J SJ   Hu Yuanxin Y   Eschenbacher William H WH   Dorn Lisa E LE   Dorn Gerald W GW  

Circulation research 20120629 5


<h4>Rationale</h4>MicroRNA-499 and other members of the myomiR family regulate myosin isoforms in pressure-overload hypertrophy. miR-499 expression varies in human disease, but results of mouse cardiac miR-499 overexpression are inconsistent, either protecting against ischemic damage or aggravating cardiomyopathy after pressure overload. Likewise, there is disagreement over direct and indirect cardiac mRNAs targeted in vivo by miR-499.<h4>Objective</h4>To define the associations between regulate  ...[more]

Similar Datasets

| S-EPMC8745647 | biostudies-literature
| S-EPMC7592094 | biostudies-literature
| S-EPMC5839292 | biostudies-literature
| S-EPMC5318290 | biostudies-literature
| S-EPMC4375369 | biostudies-literature
| S-EPMC8140057 | biostudies-literature
| S-EPMC7736330 | biostudies-literature
2022-12-21 | GSE205680 | GEO
| S-EPMC3945068 | biostudies-literature
| S-EPMC3131377 | biostudies-literature